Abstract | ETHNOPHARMACOLOGICAL RELEVANCE: Bulbus Fritillaria cirrhosa D. Don (BFC) is a Chinese traditional herbal medicine that has long been used as an indispensable component in herbal prescriptions for bronchopulmonary diseases due to its well-established strong anti- inflammation and pulmonary harmonizing effects. Interestingly, there are few case reports in traditional Chinese medicine available where they found it to contribute in anti- tumor therapies. Imperialine is one of the most favored active substances extracted from BFC and has been widely recognized as an anti-inflammatory agent. AIM OF THE STUDY: The aim of the current work is to provide first-hand evidences both in vitro and in vivo showing that imperialine exerts anti- cancer effects against non-small cell lung cancer (NSCLC), and to explore the molecular mechanism of this anti- tumor activity. It is also necessary to examine its systemic toxicity, and to investigate how to develop strategies for feasible clinical translation of imperialine. MATERIALS AND METHODS: To investigate anti-NSCLC efficacy of imperialine using both in vitro and in vivo methods where A549 cell line were chosen as in vitro model NSCLC cells and A549 tumor-bearing mouse model was constructed for in vivo study. The detailed underlying anti- cancer mechanism has been systematically explored for the first time through a comprehensive set of molecular biology methods mainly including immunohistochemistry, western blot and enzyme-linked immunosorbent assays. The toxicity profile of imperialine treatments were evaluated using healthy nude mice by examining hemogram and histopathology. An imperialine-loaded liposomal drug delivery system was developed using thin film hydration method to evaluate target specific delivery. RESULTS: The results showed that imperialine could suppress both NSCLC tumor and associated inflammation through an inflammation- cancer feedback loop in which NF-κB activity was dramatically inhibited by imperialine. The NSCLC-targeting liposomal system was successfully developed for targeted drug delivery. The developed platform could favorably enhance imperialine cellular uptake and in vivo accumulation at tumor sites, thus improving overall anti- tumor effect. The toxicity assays revealed imperialine treatments did not significantly disturb blood cell counts in mice or exert any significant damage to the main organs. CONCLUSIONS:
Imperialine exerts anti- cancer effects against NSCLC both in vitro and in vivo, and this previously unknown function is related to NF-κB centered inflammation- cancer feedback loop. Imperialine mediated anti- cancer activity is not through cytotoxicity and exhibit robust systemic safety. Furthermore, the liposome-based system we commenced would dramatically enhance therapeutic effects of imperialine while exhibiting extremely low side effects both on cellular and in NSCLC model. This work has identified imperialine as a promising novel anti- cancer compound and offered an efficient target-delivery solution that greatly facilitate practical use of imperialine.
|
Authors | Qing Lin, Mengke Qu, Hirak K Patra, Shanshan He, Luyao Wang, Xun Hu, Linyu Xiao, Yu Fu, Tao Gong, Qin He, Ling Zhang, Xun Sun, Zhirong Zhang |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 247
Pg. 112283
(Jan 30 2020)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 31605736
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Elsevier B.V. All rights reserved. |
Chemical References |
- Alkaloids
- Cevanes
- Drugs, Chinese Herbal
- Liposomes
- NF-kappa B
- peiminine
|
Topics |
- A549 Cells
- Alkaloids
(administration & dosage, adverse effects, chemistry, isolation & purification)
- Animals
- Blood Cell Count
- Carcinoma, Non-Small-Cell Lung
(drug therapy, immunology, pathology)
- Cevanes
(administration & dosage, adverse effects, chemistry, isolation & purification)
- Drugs, Chinese Herbal
(administration & dosage, adverse effects, chemistry, isolation & purification)
- Feedback, Physiological
(drug effects)
- Fritillaria
(chemistry)
- Humans
- Liposomes
- Lung Neoplasms
(drug therapy, immunology, pathology)
- Male
- Mice
- NF-kappa B
(antagonists & inhibitors, immunology)
- Toxicity Tests
- Xenograft Model Antitumor Assays
|